Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Simvastatin for VTE Prevention in Cancer
NCT02285738Phase 1Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Dec 2014
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin and simvastatin in venous thromboembolism (VTE) (6 arms), sponsored by Case Comprehensive Cancer Center. Primary endpoint: Change in average sP-selectin levels at 16 weeks. Started Dec 2014; status: completed.
02
Drugs
aspirinsimvastatin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02285738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285738.